Venetoclax plus 3+7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial

Wang, HF; Mao, LP; Yang, M; Qian, PX; Lu, H; Tong, HY; Xie, WZ; Zhou, D; Huang, X; Wang, YG; Xu, GX; Lu, Y; Wei, JY; Mai, WY; Ye, XJ; Meng, HT; Shen, YJ; Huang, J; Yu, WJ; Sun, J; Sheng, JP; Yan, XY; Jin, J; Zhu, HH

Zhu, HH (通讯作者)，Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Haematol, Hangzhou 310003, Zhejiang, Peoples R China.

LANCET HAEMATOLOGY, 2022; 9 (6): E415

Abstract

Background Adults with acute myeloid leukaemia have unsatisfactory dinical outcomes and rates of complete remission. Venetodax combined with azacytidi......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索